Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-01-04 @ 3:28 PM
Study NCT ID:
NCT03878004
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2019-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac
Sponsor:
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-14
First Submit QC Date:
None
Study First Post Date:
2019-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-16
Last Update Post Date:
2020-06-17
Last Update Post Date Type:
ACTUAL